Schedule 13G ownership disclosure
ESPERION THERAPEUTICS, INC.
Common Stock · CUSIP: 29664W105
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BB Biotech AG
Shares: 9,944,064.00 · Class: 5.0%
- Biotech Target N.V.
Shares: 9,944,064.00 · Class: 5.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-013936
- Form type
- SCHEDULE 13G/A
- Filer
- BB BIOTECH AG
- CIK
- CIK 924223
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership